Coenen Named As New Medaxes Chief
Tributes Paid Following Passing Of Former Leader Joris Van Assche
Medaxes has named Jasmien Coenen as the new managing director of the Belgian off-patent industry association, following the recent passing of former leader Joris Van Assche.
You may also be interested in...
What’s Next? Five Things To Look Out For In October
A busy October will include planned biosimilar launches and key appointments for the off-patent sector.
Greater Uptake Must Become Belgium’s ‘New Normal’
Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.
Celltrion And Rani Partner For Oral Adalimumab
Celltrion has doubled down on its alliance with Rani Therapeutics for oral pill versions of biosimilars by adding adalimumab to an existing collaboration covering ustekinumab.